Paper9514735
Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA.
Fourmy D and 2 others. J Mol Biol, 1998. Cited by 193 papers, by iCite.
Cite this record
ConductScience Library. Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. Papers, record 9514735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9514735
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Neomycin | Major topic |
| RNA, Ribosomal, 16S | Major topic |
| Binding Sites | |
| Carbohydrate Sequence | |
| Magnetic Resonance Spectroscopy | |
| Models, Molecular | |
| Molecular Sequence Data |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| GM51266-01A1 | NIGMS NIH HHS | United States | PubMed | PubMed | |
| R01GM051266 | NIH | NIH RePORTER |
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 193 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41613871 | Evolution of ribosome X-ray crystallography: from first crystals to atomic resolution. | Biophys Rev | 2025 | https://conductscience.org/library/papers/41613871 | PubMed |
| 41259288 | Aminoglycoside-Peptide Nucleic Acid (PNA) Conjugates against Gram-Negative Bacteria. | Bioconjug Chem | 2025 | https://conductscience.org/library/papers/41259288 | PubMed |
| 41226238 | Eight Triplex-Binding Molecules from Four Chemical Classes Broadly Recognize the MALAT1 Triple Helix. | Molecules | 2025 | https://conductscience.org/library/papers/41226238 | PubMed |
| 39456196 | Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics. | Biomolecules | 2024 | https://conductscience.org/library/papers/39456196 | PubMed |
| 37696823 | Geometric alignment of aminoacyl-tRNA relative to catalytic centers of the ribosome underpins accurate mRNA decoding. | Nat Commun | 2023 | https://conductscience.org/library/papers/37696823 | PubMed |
| 37671393 | Parallel G-quadruplex recognition by neomycin. | Front Chem | 2023 | https://conductscience.org/library/papers/37671393 | PubMed |
| 37273645 | Conjugates of Aminoglycosides with Stapled Peptides as a Way to Target Antibiotic-Resistant Bacteria. | ACS Omega | 2023 | https://conductscience.org/library/papers/37273645 | PubMed |
| 36350431 | A mini-review: environmental and metabolic factors affecting aminoglycoside efficacy. | World J Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/36350431 | PubMed |
| 35946799 | Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics. | ACS Infect Dis | 2022 | https://conductscience.org/library/papers/35946799 | PubMed |
| 35542650 | Discovery of a novel small molecular peptide that disrupts helix 34 of bacterial ribosomal RNA. | RSC Adv | 2019 | https://conductscience.org/library/papers/35542650 | PubMed |
| 35341941 | Identifying targets to prevent aminoglycoside ototoxicity. | Mol Cell Neurosci | 2022 | https://conductscience.org/library/papers/35341941 | PubMed |
| 34445410 | Interest of Homodialkyl Neamine Derivatives against Resistant P. aeruginosa, E. coli, and β-Lactamases-Producing Bacteria-Effect of Alkyl Chain Length on the Interaction with LPS. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445410 | PubMed |
| 32400865 | Screening for deafness-associated mitochondrial 12S rRNA mutations by using a multiplex allele-specific PCR method. | Biosci Rep | 2020 | https://conductscience.org/library/papers/32400865 | PubMed |
| 31382490 | Synthesis of Ring II/III Fragment of Kanamycin: A New Minimum Structural Motif for Aminoglycoside Recognition. | Antibiotics (Basel) | 2019 | https://conductscience.org/library/papers/31382490 | PubMed |
| 30108980 | Antifungal amphiphilic kanamycins: new life for an old drug. | Medchemcomm | 2018 | https://conductscience.org/library/papers/30108980 | PubMed |
| 30108822 | Effects of guanidino modified aminoglycosides on mammalian membranes studied using a quartz crystal microbalance. | Medchemcomm | 2017 | https://conductscience.org/library/papers/30108822 | PubMed |
| 29937831 | Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity. | J Otol | 2017 | https://conductscience.org/library/papers/29937831 | PubMed |
| 29594367 | A SERS-based multiple immuno-nanoprobe for ultrasensitive detection of neomycin and quinolone antibiotics via a lateral flow assay. | Mikrochim Acta | 2018 | https://conductscience.org/library/papers/29594367 | PubMed |
| 27884695 | Linker dependent intercalation of bisbenzimidazole-aminosugars in an RNA duplex; selectivity in RNA vs. DNA binding. | Bioorg Med Chem Lett | 2016 | https://conductscience.org/library/papers/27884695 | PubMed |
| 26818562 | Bacterial GCN5-Related N-Acetyltransferases: From Resistance to Regulation. | Biochemistry | 2016 | https://conductscience.org/library/papers/26818562 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9514735
GET https://conductscience.org/api/papers/v1/9514735/cited_by?page=2